Eon Labs Settles With U.S. For $3.5 Million
February 26th, 2010
In April 1999, the Food and Drug Administration (FDA) determined that the drug Nitroglycerin SR did not produce substantial enough results to warrant approval by the FDA for reimbursement by government programs such as Medicaid.
Despite the fact that the use of Nitroglycerin SR would not be subsidized by Government programs, Eon Labs continued to submit quarterly reports to the government that misrepresented Nitroglycerin SR’s status and failed to notify that the drug was not longer eligible for Medicaid reimbursement. The government accuses Eon Labs of knowingly causing false Medicaid claims to be filed for Nitroglycerin SR through the autumn of 2008.
The case was settled under the False Claims Act, and was brought to court by an anonymous civilian whistle blower on behalf of the United States Government. The False Claims Act entitles the whistle blower to a share of the settlement, which will be $525,000 in the Eon Labs case.
Following the reports of fraud, the Eon Labs case was investigated by the Attorney’s Office of the District of Massachusetts, the Department of Health and Human Services and the Justice Department.
Posted in Health Care Fraud, Medicaid FraudNo Comments
Subscribe: